A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Clinical trial NCT06388707 · RECRUITING

Trial details

NCT number: NCT06388707
Sponsor: NaviFUS Corporation
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Drug Resistant Epilepsy Epilepsy Seizures, Focal Seizure Seizure Disorder

Start date: 2024-09-13
Primary completion: 2026-12-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.